We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+9.56%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$812M
AUM Growth
+$219M
(+37%)
Cap. Flow
+$173M
Cap. Flow
% of AUM
21.28%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
3,095
New
215
Increased
1,249
Reduced
951
Closed
267
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$9.74M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$8.67M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$7.37M |
| 4 |
Apple
AAPL
|
+$6.37M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$5.44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.33M |
| 2 |
MGI
MoneyGram International, Inc. New
MGI
|
+$1.19M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
+$774K |
| 4 |
FLG
Flagstar Bank National Association
FLG
|
+$531K |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$438K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.72% |
| 2 | Technology | 11.11% |
| 3 | Healthcare | 9.24% |
| 4 | Industrials | 3.53% |
| 5 | Consumer Staples | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Seres Therapeutics
MCRB
$48.9M
| $1.99K | ﹤0.01% |
18
-4
| -18% | -$536 |
|
2227
Acuity Brands
AYI
$10.8B
| $1.99K | ﹤0.01% |
12
-28
| -70% | -$4.97K |
|
2228
Envista
NVST
$4.52B
| $1.99K | ﹤0.01% |
+59
| New | +$2.02K |
|
|
GDEN
2229
DELISTED
Golden Entertainment
GDEN
| $1.98K | ﹤0.01% |
53
+1
| +2% | +$41 |
|
2230
KRONOS Worldwide
KRO
$989M
| $1.97K | ﹤0.01% |
210
-387
| -65% | -$3.66K |
|
2231
Lemonade
LMND
$4.1B
| $1.97K | ﹤0.01% |
144
-62
| -30% | -$1.23K |
|
2232
First Community Bankshares
FCBC
$911M
| $1.97K | ﹤0.01% |
58
| – | – |
|
|
DO
2233
DELISTED
Diamond Offshore Drilling, Inc.
DO
| $1.97K | ﹤0.01% |
189
| – | – |
|
|
LICY
2234
DELISTED
Li-Cycle Holdings Corp.
LICY
| $1.96K | ﹤0.01% |
+51
| New | +$2.29K |
|
2235
Corcept Therapeutics
CORT
$12B
| $1.95K | ﹤0.01% |
96
-244
| -72% | -$6.12K |
|
2236
Arbutus Biopharma
ABUS
$915M
| $1.94K | ﹤0.01% |
833
+639
| +329% | +$1.53K |
|
2237
Marten Transport
MRTN
$1.22B
| $1.94K | ﹤0.01% |
98
-78
| -44% | -$1.56K |
|
2238
Amalgamated Financial
AMAL
$1.49B
| $1.94K | ﹤0.01% |
84
-251
| -75% | -$6.08K |
|
|
WIRE
2239
DELISTED
Encore Wire Corp
WIRE
| $1.93K | ﹤0.01% |
14
+9
| +180% | +$1.25K |
|
2240
Intapp
INTA
$2.91B
| $1.92K | ﹤0.01% |
77
+8
| +12% | +$177 |
|
2241
Purple Innovation
PRPL
$41.7M
| $1.92K | ﹤0.01% |
+16
| New | +$1.75K |
|
|
AIV
2242
Aimco
AIV
$383M
| $1.92K | ﹤0.01% |
269
| – | – |
|
2243
Ubiquiti
UI
$34.3B
| $1.92K | ﹤0.01% |
7
| – | – |
|
|
NGMS
2244
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $1.91K | ﹤0.01% |
+157
| New | +$2.36K |
|
2245
Acushnet Holdings
GOLF
$5.45B
| $1.91K | ﹤0.01% |
45
+4
| +10% | +$180 |
|
|
VBTX
2246
DELISTED
Veritex Holdings
VBTX
| $1.91K | ﹤0.01% |
68
| – | – |
|
2247
Credit Acceptance
CACC
$6.08B
| $1.9K | ﹤0.01% |
4
-6
| -60% | -$2.75K |
|
2248
Sensata Technologies
ST
$6.79B
| $1.9K | ﹤0.01% |
47
+44
| +1,467% | +$1.83K |
|
2249
MP Materials
MP
$9.1B
| $1.89K | ﹤0.01% |
78
-252
| -76% | -$7.64K |
|
2250
Tandem Diabetes Care
TNDM
$1.56B
| $1.89K | ﹤0.01% |
42
-14
| -25% | -$634 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Lindbrook Capital held 3,095 positions worth $812M, up 37% from $593M the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Lindbrook Capital deployed $173M of net new capital in Q4 2022, opening 215 new positions and adding to 1,249 existing holdings. Its largest new stake was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Russell 1000 Growth ETF, an estimated $1.33M trimmed.
- Lindbrook Capital's largest Q4 2022 buy was Invesco DB Commodity Index Tracking Fund: 184,095 shares worth $4.54M.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q4 2022, an estimated $9.74M increase.
- Lindbrook Capital's biggest Q4 2022 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $1.33M.
- Lindbrook Capital fully exited iShares ESG Aware MSCI USA ETF in Q4 2022, selling an estimated $215K.
- Lindbrook Capital's ten largest holdings make up 42% of its $812M portfolio in Q4 2022.
- Lindbrook Capital opened 215 new positions and closed 267 in Q4 2022.
- Lindbrook Capital's portfolio value rose 37% quarter-over-quarter to $812M.
Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.